🔎 Trials Near Me

Akèy › Kansè kanal bil (Kolangyokasinòm) › Kalifòni

Etid klinik pou Kansè kanal bil (Kolangyokasinòm) nan Kalifòni

20 etid pou Kansè kanal bil (Kolangyokasinòm) ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

A Study of PHST001 in Advanced Solid Tumors

  • Precision NextGen Oncology & Research Center, Beverly Hills
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • Stanford University School of Medicine, Palo Alto
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06840886

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

  • City of Hope (Site 107), Duarte
  • University of California at Irvine (Site 101), Orange
  • UCLA Medical Center (Site 117), Santa Monica
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07265674

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford University Medical Center, Stanford
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213791

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  • START Los Angeles, Los Angeles
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07488676

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • Stanford University, Palo Alto
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05732831

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05497531

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07619313

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

  • UCI Irvine Health, Orange
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07486713

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Precision NextGen Oncology & Research Center, Beverly Hills
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
  • University of California Los Angeles Rheumatology, Westwood, Los Angeles
Ap rekriteFaz 2
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

  • USC Norris Comprehensive Cancer Center, Los Angeles
  • LACN Aneheim Flagship Office, Los Angeles
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05874414

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

  • USC Norris Comprehensive Cancer Center, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07337525

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

  • City of Hope Nat Medical Ctr, Duarte
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07224750

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

  • City of Hope Medical Center, Duarte
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT06342414

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

  • USC Norris Comprehensive Cancer Center, Los Angeles
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07169734

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

  • University of California, Davis Comprehensive Cancer Center, Sacramento
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT06101277

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  • Cedars-Sinai Medical Center, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07458347

A Study of MGC028 in Participants With Advanced Solid Tumors

  • UCSF - Helen Diller Family Cancer Center, San Francisco
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 27, 2026 · NCT06723236

REGULUS: MRI-guided Adaptive SABR for Liver Cancers

  • Stanford University, Palo Alto
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT07223307

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Duarte
  • Massive Bio SYNERGY-AI site, Irvine
  • Massive Bio SYNERGY-AI site, La Jolla
  • ak 3 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.